Schering-Plough Animal Health - Growing And Finishing Pigs Set To Benefit As New Generation Antibiotic Gains Enteric Licence
Published:May 15, 2006
Source :Schering-Plough Animal Health
UK Pig producers with enteric conditions such as ileitis and swine dysentery have a powerful new in-feed option from Schering-Plough Animal Health. Previously licensed for treating respiratory disease, Aivlosin an entirely new macrolide is a pre-mix for medicating pig feed.
Announcing the licence extension at this year’s National Pig and Poultry Fair Schering-Plough Veterinary adviser for pigs, Ross Kelly B.V.M.S., M.R.C.V.S explained, “Enteric disease remains a costly challenge for UK pig producers.
Introduced as a feed pre-mix, Aivlosin provides a cost effective potent and rapid response to these infections, achieving a speed of action similar to most injections.
This is especially relevant for the growing pig as profitable production is dependent on optimum growth and feed conversion.” This licence provides a further extension to the growing portfolio of pig products for Schering-Plough in the UK.
Aivlosin is a prescription only product, which requires the authorisation of the herd vet. Producers should discuss any intended medication programs with their vet and supplying feed company.
